APRIL*BAFF
授权管线 · — · —
授权管线Confidentiality：公开
- INN / Generic Name
- APRIL*BAFF
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Immunology & Inflammation
- Indication
- Systemic severe myasthenia gravis; Primary membranous nephropathy
- Current Status
- 新药候选授权（UB698）· 临床前（Preclinical）
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 授权 / 共同开发（视靶点与阶段）
- MOQ
- 1 个项目
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —